Literature DB >> 11793012

Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.

E Bonora1, M Muggeo.   

Abstract

That cardiovascular disease occurs more frequently in patients with Type II (non-insulin-dependent) diabetes mellitus has been recognized for a long time. However, the extent to which hyperglycaemia contributes to atherosclerosis and cardiovascular disease is still not clear. Epidemiological studies published in recent years suggest that postprandial blood glucose might be an independent risk factor of cardiovascular disease. The main results of these studies, which are reviewed in this article, are that subjects from the general population with mild to moderate hyperglycaemia, following oral glucose load, but not in the fasting state, showed an increased cardiovascular risk. Furthermore, the post-challenge as well as postprandial glucose concentrations of subjects with Type II diabetes were found to be directly associated to incident cardiovascular disease independently of fasting glucose. Also, the correction of fasting hyperglycaemia or HbA1 c or both, disregarding the specific correction of postprandial hyperglycaemia was not found to significantly reduce the incidence of cardiovascular disease in patients with Type II diabetes. Finally, the strict control of both preprandial and postprandial hyperglycaemia yielded a substantial reduction of cardiovascular disease in Type II diabetes. Trials specifically designed to address this issue are needed to determine whether postprandial hyperglycaemia plays an independent and causative role in cardiovascular disease in patients with Type II diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11793012     DOI: 10.1007/s001250100020

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  95 in total

1.  Exposure to maternal overnutrition and a high-fat diet during early postnatal development increases susceptibility to renal and metabolic injury later in life.

Authors:  Colette M Jackson; Barbara T Alexander; Lauren Roach; Deani Haggerty; David C Marbury; Zachary M Hutchens; Elizabeth R Flynn; Christine Maric-Bilkan
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

2.  Fatigue in women with type 2 diabetes.

Authors:  Cynthia Fritschi; Laurie Quinn; Eileen D Hacker; Sue M Penckofer; Edward Wang; Marquis Foreman; Carol E Ferrans
Journal:  Diabetes Educ       Date:  2012-06-19       Impact factor: 2.140

3.  Glycaemic control is improved by 7 days of aerobic exercise training in patients with type 2 diabetes.

Authors:  C R Mikus; D J Oberlin; J Libla; L J Boyle; J P Thyfault
Journal:  Diabetologia       Date:  2012-02-04       Impact factor: 10.122

4.  Postprandial glucose monitoring further improved glycemia, lipids, and weight in persons with type 2 diabetes mellitus who had already reached hemoglobin A1c goal.

Authors:  David A Zhang; Laurence Katznelson; Ming Li
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

Review 5.  Repaglinide: a review of its use in type 2 diabetes mellitus.

Authors:  Lesley J Scott
Journal:  Drugs       Date:  2012-01-22       Impact factor: 9.546

Review 6.  Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.

Authors:  D Giugliano; A Ceriello; E Razzoli; K Esposito
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

7.  Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus.

Authors:  E Bonora; G Corrao; V Bagnardi; A Ceriello; M Comaschi; P Montanari; J B Meigs
Journal:  Diabetologia       Date:  2006-03-11       Impact factor: 10.122

8.  Counterpoint: postprandial glucose levels are not a clinically important treatment target.

Authors:  Mayer B Davidson
Journal:  Diabetes Care       Date:  2010-08       Impact factor: 19.112

Review 9.  Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy.

Authors:  P Spallarossa; A Barsotti; R Cordera; G Ghigliotti; D Maggi; C Brunelli
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

10.  Influence of Postprandial Hyperglycemic Conditions on Arterial Stiffness in Patients With Type 2 Diabetes.

Authors:  Daniel Gordin; Markku Saraheimo; Jaana Tuomikangas; Aino Soro-Paavonen; Carol Forsblom; Karri Paavonen; Birgit Steckel-Hamann; Francois Vandenhende; Loizos Nicolaou; Imre Pavo; Veikko Koivisto; Per-Henrik Groop
Journal:  J Clin Endocrinol Metab       Date:  2016-01-05       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.